Axsometherapeutics
Associate Director, Patient Services (HUB Operations)
New York, NY. Posted 9 months ago
The role
This person will lead the establishment and growth of a new Patient Services Hub. They will develop, implement, and oversee Hub operations to ensure patient access to therapies and support services.
What you will do
- Support the design, development, and implementation of the Patient Services Hub.
- Develop strategies to enhance patient and provider experience.
- Ensure compliance with regulatory requirements and HIPAA regulations.
- Act as the primary point of contact for the HUB administrator and operations.
- Develop and monitor key performance metrics to assess program effectiveness.
- Analyze program processes to improve efficiency and reduce costs.
- Plan and execute training programs for Hub staff and internal teams.
- Monitor and analyze Hub performance data and implement corrective actions.
- Collaborate with Field Reimbursement Managers and Market Access leadership.
- Respond to and resolve complex escalated issues.
Required qualifications
- Bachelor’s Degree
- 7+ years of experience in Patient Service HUB management within the biotech industry
- Experience in leading patient support (HUB) programs
- Experience leading complex product launches within the patient support space
- Experience in managing complex and dynamic projects, programs, and teams
- Analytical mindset and experience directing and managing activities critical to home office and field sales
- Strong understanding of industry trends in the pharmaceutical patient services landscape
- Problem-solving mindset with a lean-forward approach and ability to think critically
- Ability to work on site Monday, Tuesday & Thursday
Nice to have
- Previous product launch experience, preferably in the CNS space
Benefits
- Annual bonus
- Significant equity
- Generous benefits package
About the company
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Their neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness, and migraine.